New Jersey Resources (NJR) Reports Q1 EPS of $1.56, Beats on Revenues; Boosts FY18 EPS Guidance Well Above Consensus
Get Alerts NJR Hot Sheet
Price: $55.60 +0.11%
Financial Fact:
OPERATING INCOME (LOSS): 42.48M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
OPERATING INCOME (LOSS): 42.48M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Note: EPS may not be comparable
New Jersey Resources (NYSE: NJR) reported Q1 EPS of $1.56, versus $0.59 reported last year. Revenue for the quarter came in at $705.3 million versus the consensus estimate of $564.47 million.
- Consolidated net income was $123.7 million for the first quarter of fiscal 2018, compared with $34.9 million for the same period in fiscal 2017. This includes an estimated benefit from tax reform of $57.6 million due to revaluation of deferred taxes recognized during this quarter.
- Consolidated net financial earnings (NFE), a non-GAAP financial measure, were $135.3 million for the first quarter of fiscal 2018, compared with $40.4 million during the same period in fiscal 2017.
- NJR raised its fiscal 2018 NFE guidance to $2.55 to $2.65 from $1.75 to $1.85 per share.
- Long-term annual NFE per share growth rate range adjusted to 6 to 8 percent.
- Energy Services reported first-quarter fiscal 2018 NFE of $20.3 million, compared with $3.5 million during the same period in fiscal 2017, driven by strong market demand due to colder weather in December 2017.
GUIDANCE:
New Jersey Resources sees FY2018 EPS of $2.55-$2.65, versus the consensus of $1.82.
For earnings history and earnings-related data on New Jersey Resources (NJR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
Corporate News, Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share